💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueLearn More

Zomedica Pharmaceuticals Corp (ZOM)

NYSE
Currency in USD
Disclaimer
0.1279
+0.0011(+0.87%)
Closed
After Hours
0.1267-0.0012(-0.9382%)
ZOM Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.12610.1318
52 wk Range
0.12000.2285
Prev. Close
0.1268
Open
0.129
Day's Range
0.1261-0.1318
52 wk Range
0.12-0.2285
Volume
2,563,746
Average Volume (3m)
3,208,087
1-Year Change
-29.67%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
ZOM Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
0.4400
Upside
+244.0188%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Zomedica Pharmaceuticals Corp Company Profile

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.

Compare ZOM to Peers and Sector

Metrics to compare
ZOM
Peers
Sector
Relationship
P/E Ratio
−2.2x−7.2x−0.6x
PEG Ratio
0.010.010.00
Price/Book
0.6x3.3x2.6x
Price / LTM Sales
4.8x4.1x3.1x
Upside (Analyst Target)
-42.5%58.3%
Fair Value Upside
Unlock−8.3%8.8%Unlock

People Also Watch

2.110
NNDM
+1.44%
0.1300
IDEX
-50.00%
0.015
SPWRQ
-63.17%
1.3600
ATOS
+2.26%
0.988
MVIS
+1.23%

FAQ

What Is the Zomedica Pharma (ZOM) Stock Price Today?

The Zomedica Pharma stock price today is 0.1279

What Stock Exchange Does Zomedica Pharma Trade On?

Zomedica Pharma is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Zomedica Pharma?

The stock symbol for Zomedica Pharma is "ZOM."

What Is the Zomedica Pharma Market Cap?

As of today, Zomedica Pharma market cap is 125.34M.

What is Zomedica Pharma Earnings Per Share?

The Zomedica Pharma EPS is -0.057.

What Is the Next Zomedica Pharma Earnings Date?

Zomedica Pharma will release its next earnings report on Nov 11, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.